Molecular Psychiatry

Molecular Psychiatry is a monthly peer-reviewed journal published by Springer Nature as part of its Nature Portfolio, founded in 1996 and devoted to cutting-edge research on the biological mechanisms underlying psychiatric disorders and their treatment, with a 2025 Journal Impact Factor of 10.4《分子精神病学》（Molecular Psychiatry）是（Springer Nature）旗下（Nature Portfolio）出版的月刊同行评审期刊，1996 年创刊，致力于发表揭示精神疾病及其治疗生物学机制的前沿研究，2025 年影响因子为 10.4。

Scope

• The journal publishes cutting-edge work that advances our understanding of the biological mechanisms underlying psychiatric disorders and their treatment, with emphasis on studies at the interface of preclinical and clinical research该刊发表推进对精神疾病及其治疗背后生物学机制理解的前沿成果，强调临床前研究与临床研究交叉界面的工作。
• Its studies span the cellular, molecular, integrative, clinical, imaging and psychopharmacological levels of analysis其研究覆盖细胞、分子、整合、临床、影像与精神药理学等分析层面。
• Besides fundamental mechanistic research, it seeks high-quality clinical studies, including observational research, biomarker investigations and clinical trials, that directly translate biological insights into advances in patient care除基础机制研究外，该刊还遴选高质量的临床研究，包括观察性研究、生物标志物研究与临床试验，以将生物学洞见直接转化为患者护理的进步。
• Besides original articles, the journal features news and commentary, reviews and immediate communications除原创文章外，该刊还刊发新闻与评论、综述以及即时通讯。
• The publisher ranks the journal among the top ten psychiatry journals and highlights its international reputation for high-impact research in psychiatry and neurosciences出版方将该刊列为精神病学排名前十的期刊，并强调其在精神病学与神经科学领域高影响力研究的国际声誉。
• The journal is a hybrid one, so authors may choose the subscription route or immediate gold open access through an article-processing charge, and open-access articles appear under Creative Commons licences该刊为混合出版模式期刊，作者可选择订阅路径，或支付文章处理费以即时金色开放获取发表，开放获取文章以（Creative Commons）许可发布。
• It is abstracted and indexed in the Science Citation Index Expanded, MEDLINE, Scopus, EMBASE, PsycINFO, Current Contents and dozens of further databases该刊被（SCIE）、（MEDLINE）、（Scopus）、（EMBASE）、（PsycINFO）、（Current Contents）等数十个数据库收录。
• Its 2025 metrics include a five-year impact factor of 12.2, a Source Normalized Impact per Paper of 3.181, a SCImago Journal Rank of 4.602, more than eleven million downloads and more than ninety thousand Altmetric mentions其 2025 年指标包括五年影响因子 12.2、（SNIP）3.181、（SJR）4.602，全年下载量超过 1100 万次，（Altmetric）提及超过 9 万次。

History

• The journal was founded in 1996 and its first issue, volume 1 number 1, appeared in March 1996, originally published by Stockton Press该刊于 1996 年创刊，第 1 卷第 1 期于 1996 年 3 月面世，最初由（Stockton Press）出版。
• Julio Licinio was the founding editor-in-chief, and his opening editorial set out the integration of molecular medicine and clinical psychiatry（Julio Licinio）是创刊主编，其创刊寄语阐述了分子医学与临床精神病学的融合。
• Publishing moved to Nature Publishing Group around 2000, and the journal is now published by Springer Nature约 2000 年起改由（Nature Publishing Group）出版，现由（Springer Nature）出版。
• It appeared bimonthly in its early years and has been issued monthly since 2002该刊早期为双月刊，2002 年起改为月刊。
• The founding editor says he raised the journal from its launch to the number one position worldwide in psychiatry within thirteen years, and he later founded three further Springer Nature journals, The Pharmacogenomics Journal, Translational Psychiatry and Discover Mental Health创刊主编自述用十三年时间将该刊从零带至全球精神病学排名第一，此后又创办了（The Pharmacogenomics Journal）、（Translational Psychiatry）与（Discover Mental Health）三种（Springer Nature）期刊。
• Its recent impact factors were 15.992 in 2021, 13.437 in 2022, 10.1 in 2024 and 10.4 in 2025其近年影响因子分别为 2021 年 15.992、2022 年 13.437、2024 年 10.1、2025 年 10.4。
• The journal marked its twentieth anniversary with a 2015 editorial looking back on two decades of publication该刊在 2015 年发表创刊二十周年纪念社评，回顾二十年的出版历程。

Editors

• Julio Licinio, editor-in-chief since the journal was founded, is State University of New York Distinguished Professor of psychiatry at Upstate Medical University and Matthew Flinders Distinguished Professor of Psychiatry at Flinders University in Australia自创刊起担任主编的（Julio Licinio）是美国（Upstate Medical University）精神病学杰出教授，并任澳大利亚（Flinders University）精神病学讲席教授。
• He holds a doctorate in medicine and a PhD, previously chaired the Department of Psychiatry at the University of Miami and spent 1999 to 2006 at the University of California, Los Angeles（Julio Licinio）拥有医学博士与哲学博士学位，曾任迈阿密大学精神病学系主任，1999 年至 2006 年任职于加州大学洛杉矶分校。
• Ma-Li Wong is the managing editor, also at Upstate Medical University in the United States（Ma-Li Wong）任管理编辑，同样任职于美国（Upstate Medical University）。
• The associate editors are Revathy Uthaiah Chottekalapanda of Weill Cornell Medicine, Gail Davies of the University of Edinburgh, Kim Q. Do of the Lausanne University Hospital, Muhammad A. Parvaz of the Icahn School of Medicine at Mount Sinai, Joao de Quevedo of the University of Texas Health Science Center at Houston and Weihua Yue of Peking University Sixth Hospital副主编包括（Revathy Uthaiah Chottekalapanda）（（Weill Cornell Medicine））、（Gail Davies）（（University of Edinburgh））、（Kim Q. Do）（（Lausanne University Hospital））、（Muhammad A. Parvaz）（（Icahn School of Medicine at Mount Sinai））、（Joao de Quevedo）（（University of Texas Health Science Center at Houston））与（Weihua Yue）（北京大学第六医院）。
• According to his council biography, he edited and published 44 articles by nine Nobel Prize winners in the seven years up to 2024据其学会理事会简介，截至 2024 年的七年间他编辑发表了 9 位诺贝尔奖得主的 44 篇论文。
• Manuscript queries are directed to the editorial office at MolecularPsychiatry@us.nature.com稿件咨询请联系编辑部邮箱（MolecularPsychiatry@us.nature.com）。